226 related articles for article (PubMed ID: 18646185)
1. Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations.
Glaser SL; Gulley ML; Clarke CA; Keegan TH; Chang ET; Shema SJ; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Anton-Culver H; Ambinder RF
Int J Cancer; 2008 Oct; 123(7):1499-507. PubMed ID: 18646185
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein-Barr virus.
Glaser SL; Clarke CA; Chang ET; Yang J; Gomez SL; Keegan TH
Cancer Causes Control; 2014 Jun; 25(6):709-25. PubMed ID: 24722952
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin lymphoma incidence in ethnic enclaves in California.
Glaser SL; Chang ET; Clarke CA; Keegan TH; Yang J; Gomez SL
Leuk Lymphoma; 2015; 56(12):3270-80. PubMed ID: 25899402
[TBL] [Abstract][Full Text] [Related]
4. Neighborhood socioeconomic status and Hodgkin's lymphoma incidence in California.
Clarke CA; Glaser SL; Keegan TH; Stroup A
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1441-7. PubMed ID: 15941953
[TBL] [Abstract][Full Text] [Related]
5. Exposure to childhood infections and risk of Epstein-Barr virus--defined Hodgkin's lymphoma in women.
Glaser SL; Keegan TH; Clarke CA; Trinh M; Dorfman RF; Mann RB; DiGiuseppe JA; Ambinder RF
Int J Cancer; 2005 Jul; 115(4):599-605. PubMed ID: 15700307
[TBL] [Abstract][Full Text] [Related]
6. HLA expression and HLA type associations in relation to EBV status in Hispanic Hodgkin lymphoma patients.
Fletcher LB; Veenstra RN; Loo EY; Hwang AE; Siddiqi IN; Visser L; Hepkema BG; Nolte IM; van den Berg A; Cozen W; Diepstra A
PLoS One; 2017; 12(3):e0174457. PubMed ID: 28334025
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus (EBV) and Hodgkin's disease in a multi-ethnic population in Malaysia.
Peh SC; Looi LM; Pallesen G
Histopathology; 1997 Mar; 30(3):227-33. PubMed ID: 9088951
[TBL] [Abstract][Full Text] [Related]
8. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
Koh YW; Yoon DH; Suh C; Huh J
Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis and cell cycle-related genes and proteins in classical Hodgkin lymphoma: application of tissue microarray technique.
Wang J; Taylor CR
Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):206-13. PubMed ID: 12966346
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
[TBL] [Abstract][Full Text] [Related]
11. Disparities in survival after Hodgkin lymphoma: a population-based study.
Keegan TH; Clarke CA; Chang ET; Shema SJ; Glaser SL
Cancer Causes Control; 2009 Dec; 20(10):1881-92. PubMed ID: 19557531
[TBL] [Abstract][Full Text] [Related]
12. Expression of Epstein-Barr virus in Hodgkin lymphoma in a population of United Arab Emirates nationals.
Al-Salam S; John A; Daoud S; Chong SM; Castella A
Leuk Lymphoma; 2008 Sep; 49(9):1769-77. PubMed ID: 18661399
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.
Myriam BD; Sonia Z; Hanene S; Teheni L; Mounir T
J Infect Chemother; 2017 Mar; 23(3):121-130. PubMed ID: 28034523
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Epstein-Barr virus presence in Hodgkin lymphoma in pediatric versus adult Argentine patients.
De Matteo E; Barón AV; Chabay P; Porta J; Dragosky M; Preciado MV
Arch Pathol Lab Med; 2003 Oct; 127(10):1325-9. PubMed ID: 14521462
[TBL] [Abstract][Full Text] [Related]
15. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
[TBL] [Abstract][Full Text] [Related]
16. Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study.
Linabery AM; Erhardt EB; Fonstad RK; Ambinder RF; Bunin GR; Ross JA; Spector LG; Grufferman S
Int J Cancer; 2014 Sep; 135(6):1454-69. PubMed ID: 24523151
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.
Glaser SL; Lin RJ; Stewart SL; Ambinder RF; Jarrett RF; Brousset P; Pallesen G; Gulley ML; Khan G; O'Grady J; Hummel M; Preciado MV; Knecht H; Chan JK; Claviez A
Int J Cancer; 1997 Feb; 70(4):375-82. PubMed ID: 9033642
[TBL] [Abstract][Full Text] [Related]
18. Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea.
Koh YW; Kang HJ; Yoon DH; Suh C; Kim JE; Kim CW; Huh J
Ann Hematol; 2013 Dec; 92(12):1653-60. PubMed ID: 23832190
[TBL] [Abstract][Full Text] [Related]
19. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
